BRYOMOLECULES - D6.4 Policy brief 1

In this deliverable we present a preliminary policy brief outlining the policy implications directlyrelated to BRYOMOLECULES implementation and expected outcomes. These implications arepresented under different contextual groups, covering the current regulatory frameworks for theproduction of bioactive molecules from engineered species, the EU plans and goals forbiodiversity conservation and circular economy implementation, as well as social andconsumers acceptances of biotechnology-based products.This first policy brief has the role of providing short summaries for the policymakers in the fieldsof biodiversity, bryophyte conservation and the environmental sustainability of circular economyand biotechnology-based metabolic engineering processes for added-value secondarymetabolite production. A final policy brief will be produced at the end of the project (M36) drawingfrom the project outcomes generated and translating them into actionable policyrecommendations. The final policy brief will provide a comprehensive overview of the policyimplications associated to BRYOMOLECULES outputs and a set of recommendations for thepolicymakers. Do you want to know more about BRYOMOLECULES? Visit our project website: https://bryomolecules.eu

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-06-29
DOI
https://doi.org/10.5281/zenodo.21039712
Primary Topic
Bioeconomy and Sustainability Development
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

BRYOMOLECULES - D6.4 Policy brief 1

Stefania Vitale
Zenodo (CERN European Organization for Nuclear Research)
Bioeconomy and Sustainability Development
article

BRYOMOLECULES - D6.4 Policy brief 1

Stefania Vitale
article en

Abstract

In this deliverable we present a preliminary policy brief outlining the policy implications directlyrelated to BRYOMOLECULES implementation and expected outcomes. These implications arepresented under different contextual groups, covering the current regulatory frameworks for theproduction of bioactive molecules from engineered species, the EU plans and goals forbiodiversity conservation and circular economy implementation, as well as social andconsumers acceptances of biotechnology-based products.This first policy brief has the role of providing short summaries for the policymakers in the fieldsof biodiversity, bryophyte conservation and the environmental sustainability of circular economyand biotechnology-based metabolic engineering processes for added-value secondarymetabolite production. A final policy brief will be produced at the end of the project (M36) drawingfrom the project outcomes generated and translating them into actionable policyrecommendations. The final policy brief will provide a comprehensive overview of the policyimplications associated to BRYOMOLECULES outputs and a set of recommendations for thepolicymakers. Do you want to know more about BRYOMOLECULES? Visit our project website: https://bryomolecules.eu

Zenodo (CERN European Organization for Nuclear Research)
European Science Foundation (FR)
European Commission
Life in Land
Openalex Percentile: Top 5%
Bioeconomy and Sustainability Development
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

BRYOMOLECULES - D6.4 Policy brief 1 — Stefania Vitale · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS